Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV270
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,568
Award facts
- Contract value 100% obligated
- $28,568.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,568.14 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 6, 2026, with completion scheduled for January 7, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, making this procurement critical for military and federal healthcare system operations.
This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., holds the overarching IDC with the Defense Logistics Agency through December 31, 2031, positioned to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen's role as a prime pharmaceutical vendor reflects its significant position in the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialized medications and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FV270?
SPE2DR26FV270 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV270 worth?
The government has obligated $28,568 on SPE2DR26FV270.
Is contract SPE2DR26FV270 an order under another contract?
Yes. SPE2DR26FV270 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV270 competed?
The extent of competition for SPE2DR26FV270 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award